Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.044 SEK | 0.00% | +26.44% | -53.68% |
Business Summary
Number of employees: 5
Sales per Business
SEK in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Prognostic Gene Test
100.0
%
| 1 | 100.0 % | 1 | 100.0 % | +98.59% |
Sales per region
SEK in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Sweden
100.0
%
| 1 | 100.0 % | 1 | 100.0 % | +98.59% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Fredrik Persson
CEO | Chief Executive Officer | - | 01/17/01 |
Lars Anders Koch
DFI | Director of Finance/CFO | - | 31/23/31 |
Emelie Berglund
CTO | Chief Tech/Sci/R&D Officer | - | - |
Gerald Andriole
CTO | Chief Tech/Sci/R&D Officer | - | 05/23/05 |
Chief Operating Officer | 52 | 01/20/01 | |
Katarina Sjoberg
LAW | General Counsel | - | - |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | - | 01/13/01 | |
Director/Board Member | 72 | 01/19/01 | |
Michael Häggman
BRD | Director/Board Member | - | 01/18/01 |
Anders Lundberg
CHM | Chairman | - | 01/17/01 |
Mattias Prage
BRD | Director/Board Member | - | 01/22/01 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 119,460,007 | 14,952,566 ( 12.52 %) | 0 | 12.52 % |
Company contact information
Sector
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-53.68% | 4.03M | |
-15.21% | 8.79B | |
+67.50% | 4.19B | |
-4.03% | 2.48B | |
-42.54% | 2.29B | |
-6.49% | 1.97B | |
-20.45% | 1.56B | |
-41.24% | 1.22B | |
+10.26% | 1.13B | |
+18.74% | 933M |
- Stock Market
- Equities
- PROGEN Stock
- Company Prostatype Genomics AB